Social, Economic and Overall Health Impacts of COVID-19 on People Living with Disabilities in King County, WA

Int J Environ Res Public Health. 2022 Aug 24;19(17):10520. doi: 10.3390/ijerph191710520.

Abstract

The COVID-19 pandemic and the associated mitigation measures to reduce the spread of disease affected the social, economic, and overall health of individuals. Quantitative administrative datasets typically did not contain demographic information that allowed for reporting or analysis of the impacts of COVID-19 on people living with disabilities. Understanding the experiences of this population during the pandemic can inform the design of public health responses that are more robust and better connected to community. This paper describes a qualitative participatory study with a diverse sample of people living with disabilities in King County, WA. Through 2 listening sessions and 35 semi-structured interviews, it examines what impacts COVID-19 brought for people living with disabilities; elucidates the supports that were helpful in addressing COVID-19 impacts; examines inequities faced by the disability community; and sheds light on how to engage with this community to inform the public health emergency response. The process, protocols, findings, and lessons learned are replicable by other local health departments and could be incorporated as part of routine data collection and considered for future public health emergencies.

Keywords: COVID-19; community engagement; economic; health disparities; health equity; people living with disabilities; qualitative study; social.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • COVID-19* / epidemiology
  • Disabled Persons*
  • Humans
  • Pandemics
  • Qualitative Research
  • Washington / epidemiology

Grants and funding

This work is funded by Public Health-Seattle and King County, the Washington State Department of Health, and the Centers for Disease Control and Prevention’s (CDC’s) Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases cooperative agreement (CK19-1904).